Literature DB >> 21486316

Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.

Atholl Johnston1, Roland Asmar, Björn Dahlöf, Kate Hill, David Albert Jones, Jens Jordan, Michael Livingston, Graham Macgregor, Michael Sobanja, Panagiotis Stafylas, Enrico Agabiti Rosei, José Zamorano.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21486316      PMCID： PMC3243005          DOI： 10.1111/j.1365-2125.2011.03987.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  "Inactive" excipients such as Cremophor can affect in vivo drug disposition.

Authors:  Cristoph Wandel; Richard B Kim; C Michael Stein
Journal:  Clin Pharmacol Ther       Date:  2003-05       Impact factor: 6.875

2.  An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.

Authors:  Panagiotis C Stafilas; Panteleimon A Sarafidis; Anastasios N Lasaridis; Vassilios H Aletras; Dimitris A Niakas
Journal:  Am J Hypertens       Date:  2005-09       Impact factor: 2.689

3.  Three generations of cyclosporine a formulations: an in vitro comparison.

Authors:  Katrin Thomas; Christoph Koelwel; Uwe Machei; Lothar Färber; Achim Göpferich
Journal:  Drug Dev Ind Pharm       Date:  2005-05       Impact factor: 3.225

4.  Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid.

Authors:  Matthew M Murawski; Tamer Abdelgawad
Journal:  Am J Manag Care       Date:  2005-01       Impact factor: 2.229

5.  Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.

Authors:  Yorki Tayrouz; Reinhard Ding; Jürgen Burhenne; Klaus-Dieter Riedel; Johanna Weiss; Torsten Hoppe-Tichy; Walter Emil Haefeli; Gerd Mikus
Journal:  Clin Pharmacol Ther       Date:  2003-05       Impact factor: 6.875

6.  Cost of switching hypertensive patients from enalapril maleate to lisinopril.

Authors:  E M Lindgren-Furmaga; A A Schuna; N L Wolff; T L Goodfriend
Journal:  Am J Hosp Pharm       Date:  1991-02

Review 7.  Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.

Authors:  Peter A Meredith
Journal:  Curr Med Res Opin       Date:  2009-09       Impact factor: 2.580

8.  Differences in serum concentrations of and responses to generic verapamil in the elderly.

Authors:  B L Carter; M A Noyes; R W Demmler
Journal:  Pharmacotherapy       Date:  1993 Jul-Aug       Impact factor: 4.705

9.  Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.

Authors:  M J Pouwels; P M Hooymans; G C van der Aa; F W Gribnau
Journal:  DICP       Date:  1991-10

10.  Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand.

Authors:  Y Gomez; E Adams; J Hoogmartens
Journal:  J Pharm Biomed Anal       Date:  2004-02-04       Impact factor: 3.935
View more
  21 in total

1.  Comment on: Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe by Johnston et al.

Authors:  John B Warren; Kersti Oselin
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

2.  Is there a need for a formulary of clinically interchangeable medicines to guide generic substitution in Saudi Arabia?

Authors:  Alian A Alrasheedy; Mohamed Azmi Hassali; Hisham Aljadhey; Mohamed Izham Mohamed Ibrahim; Saleh Karamah Al-Tamimi
Journal:  J Young Pharm       Date:  2013-07-08

3.  Systematic literature review of the methodology for developing pharmacotherapeutic interchange guidelines and their implementation in hospitals and ambulatory care settings.

Authors:  Maria Adrover-Rigo; Maria-Dolores Fraga-Fuentes; Francesc Puigventos-Latorre; Iciar Martinez-Lopez
Journal:  Eur J Clin Pharmacol       Date:  2018-10-19       Impact factor: 2.953

Review 4.  Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients.

Authors:  Jayant Kumar Kairi; Ashok Kumar Sharma
Journal:  J Clin Diagn Res       Date:  2017-08-01

5.  Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics.

Authors:  Aishwarya Vijay; Ravi Gupta; Patrick Liu; Sanket S Dhruva; Nilay D Shah; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2019-10-17       Impact factor: 5.128

6.  Impact of generic substitution practice on care of diabetic patients.

Authors:  Olubukola O Oyetunde; Bolajoko A Aina; Fola Tayo
Journal:  Int J Clin Pharm       Date:  2014-04-10

7.  Impact of brand-name drug worship and expectation psychology on antidepressant efficacy.

Authors:  Jian Cai; Meirong Ye; Chunhua Fei; Feng Xu
Journal:  Int J Clin Exp Med       Date:  2013-09-01

8.  Evaluating patients' perceptions regarding generic medicines in Jordan.

Authors:  Faris El-Dahiyat; Reem Kayyali
Journal:  J Pharm Policy Pract       Date:  2013-06-13

Review 9.  A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-05       Impact factor: 2.483

10.  Development and evaluation of a computerised clinical decision support system for switching drugs at the interface between primary and tertiary care.

Authors:  Markus G Pruszydlo; Stefanie U Walk-Fritz; Torsten Hoppe-Tichy; Jens Kaltschmidt; Walter E Haefeli
Journal:  BMC Med Inform Decis Mak       Date:  2012-11-27       Impact factor: 2.796
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.